Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Patient, Investigator, Nurse, Carer Questionnaire (PINC-Q): a cross-sectional, retrospective, non-interventional study exploring the impact of less frequent medication administration with paliperidone palmitate 3-monthly as maintenance treatment for schizophrenia.
Pungor K, Sanchez P, Pappa S, Attal J, Leopold K, Steegen G, Vita A, Marsella C, Verrijcken C, Lahaye M, Wooller A. Pungor K, et al. BMC Psychiatry. 2021 Jun 9;21(1):300. doi: 10.1186/s12888-021-03305-z. BMC Psychiatry. 2021. PMID: 34107886 Free PMC article.
Symptomatic and functional outcomes after treatment with paliperidone palmitate 3-month formulation for 52 weeks in patients with clinically stable schizophrenia.
Garcia-Portilla MP, Llorca PM, Maina G, Bozikas VP, Devrimci-Ozguven H, Kim SW, Bergmans P, Usankova I, Pungor K. Garcia-Portilla MP, et al. Among authors: pungor k. Ther Adv Psychopharmacol. 2020 May 25;10:2045125320926347. doi: 10.1177/2045125320926347. eCollection 2020. Ther Adv Psychopharmacol. 2020. PMID: 32518617 Free PMC article.
Comparison of Relapse Prevention with 3 Different Paliperidone Formulations in Patients with Schizophrenia Continuing versus Discontinuing Active Antipsychotic Treatment: A Post-Hoc Analysis of 3 Similarly Designed Randomized Studies.
Mathews M, Gopal S, Singh A, Nuamah I, Pungor K, Tan W, Soares B, Kim E, Savitz AJ. Mathews M, et al. Among authors: pungor k. Neuropsychiatr Dis Treat. 2020 Jun 19;16:1533-1542. doi: 10.2147/NDT.S221242. eCollection 2020. Neuropsychiatr Dis Treat. 2020. PMID: 32606705 Free PMC article.
Relapse and Treatment Adherence in Patients with Schizophrenia Switching from Paliperidone Palmitate Once-Monthly to Three-Monthly Formulation: A Retrospective Health Claims Database Analysis.
Li G, Keenan A, Daskiran M, Mathews M, Nuamah I, Orman C, Joshi K, Singh A, Godet A, Pungor K, Gopal S. Li G, et al. Among authors: pungor k. Patient Prefer Adherence. 2021 Oct 2;15:2239-2248. doi: 10.2147/PPA.S322880. eCollection 2021. Patient Prefer Adherence. 2021. PMID: 34629867 Free PMC article.
14 results